Collagen and Gelatin Market Size
The collagen & gelatin market size was valued at USD 5,547.17 million in 2025 and is estimated to reach USD 9,036.48 million by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035).
Collagen peptide is a cold-soluble and easily digested type of collagen. It is the essential building block that makes up about 30% of the human body's protein. Collagen peptides contain higher concentrations of glycine, hydroxyproline, and proline. Likewise, gelatin is primarily composed of two components, such as proline and amino acid glycine. It is derived from animal bones, lungs, and fibrous tissues. Gelatin is essential for proper hair, skin, and nail development, weight control, and optimal immune function.
Key Takeaways
- Market value is projected to exceed USD 9.0 billion by 2035, reflecting steady demand across healthcare, nutrition, cosmetics, and food processing applications.
- North America remains the largest regional market, supported by high healthcare expenditure, chronic disease prevalence, and advanced biomedical research.
- Asia-Pacific represents the fastest-growing regional opportunity, driven by aging populations, increasing research activities, expanding healthcare infrastructure, and growing meat production.
- Collagen products continue to account for the leading product segment, supported by broad adoption in nutraceuticals, cosmetics, and regenerative medicine.
- Regenerative medicine continues to create new commercial opportunities, particularly for premium collagen formulations and medical-grade gelatin products.
- Manufacturers continue investing in product innovation and expansion strategies to strengthen their global market position and broaden application areas.
- Regulatory compliance and raw material sourcing remain important strategic considerations, particularly for bovine- and porcine-derived collagen products.
Market Scope
| Metrics | Details |
| Market Size (2025) | USD 5,547.17 Million |
| Forecast Market Size (2035) | USD 9,036.48 Million |
| CAGR (2026-2035) | 5.00% |
| Historic Years | 2023-2024 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | By Product Type, By Application, By Source, By Region |
| Largest Regional Market | North America |
| Fastest Growing Region | Asia-Pacific |
For more insights - Download the Sample
Collagen and Gelatin Market Dynamics
The global collagen & gelatin market is growing due to the increasing prevalence of chronic diseases, rapid growth in aging populations, and increased funding for regenerative medicines are essential factors driving the global demand for collagen & gelatin for regenerative medication. Moreover, emerging economies, such as Asia-Pacific and South America, offer significant opportunities in these regions, mainly due to increased life expectancy resulting in chronic diseases and increased meat production.
The rising prevalence of chronic diseases drives the growth of the market
Collagen & gelatin are present in the human body, particularly in the skin and bones. The normal development of collagen in the body declines after a certain age. Lack of collagen causes chronic diseases such as osteoporosis, bone and joint pain, chronic wounds, cardiovascular diseases, and other neurodegenerative disorders. These chronic diseases result in organ and tissue destruction, leading to the creation of treatments that can restore tissues. For instance, according to the Centres for disease control and Prevention (CDC), the in United States, cardiovascular diseases are the leading cause of death globally, accounting for 697,000 people deaths per year in 2020.
Strict regulations and the presence of substitutes for collagen and gelatin
Collagen derived from bovine and porcine sources carries the risk of disease transmission, which is the primary constraint on the demand for collagen & gelatin. Another aspect that hinders the target market is the tight limitations on these supplements by the European Union. Moreover, the increasing use of biomaterials, which alternate to collagen & gelatin, is a significant challenge for the growth of the collagen & gelatin market in the forecast period.
Market Opportunities
Investment opportunities are becoming increasingly attractive across premium collagen peptides, pharmaceutical-grade gelatin, biomedical scaffolds, regenerative medicine, and functional nutrition products.
Healthcare companies can capitalize on increasing hospital and clinical adoption of collagen-based biomaterials, while food manufacturers continue incorporating collagen into functional beverages, protein supplements, and nutritional products aimed at wellness-conscious consumers.
Emerging economies across Asia-Pacific and South America offer additional expansion potential as healthcare infrastructure develops, life expectancy rises, and consumer awareness regarding preventive healthcare continues to improve. Companies capable of ensuring regulatory compliance, high-quality raw material sourcing, and application-specific product customization are likely to strengthen their competitive positioning over the coming decade.
Collagen and Gelatin Market Segment Analysis
The collagen segment is expected to hold the largest market share in the global collagen & gelatin market
The collagen segment dominating growth is primarily driven because increasing end-use applications such as growing usage in the food & beverage industry and an upsurge in demand from the cosmetics industry. Although, partial hydrolysis of collagen contributes to the formation of gelatin. The gelatin segment dominates the market due to its high use in the food & beverage, cosmetics, and medical industries. Also, the growing number of chronic disease patients and the increasing number of aging shares of the entire population in developing countries are further estimated to lead the growth of the segment worldwide during the forecast period.
Collagen and Gelatin Market Regional Analysis
North America
North America continues to account for the largest share of the global collagen and gelatin market. Strong healthcare infrastructure, widespread adoption of nutritional supplements, substantial biomedical research investment, and high prevalence of chronic diseases contribute to sustained regional demand.
The United States remains the primary revenue contributor, supported by growing utilization across healthcare, pharmaceuticals, functional foods, and regenerative medicine applications.
Europe
European market growth is influenced by advanced healthcare systems and established food and pharmaceutical industries. However, strict regulatory oversight concerning animal-derived ingredients requires manufacturers to maintain rigorous quality standards and compliance practices, shaping supplier competition throughout the region.
Asia-Pacific
Asia-Pacific is expected to deliver the fastest growth throughout the forecast period. Rapid population aging in countries including China and India, increasing research involving collagen-based products, expanding healthcare investment, and growing production of animal-derived raw materials collectively strengthen regional growth prospects.
Growing consumer spending on nutrition and beauty products further supports expanding demand across both consumer and medical applications.
Collagen and Gelatin Market Companies and Competitive Landscape
The collagen & gelatin market is highly competitive, owing to big market players in the industry. The key collagen & gelatin players which are contributing to the growth of the global market include Rousselot, Collagen Solutions Plc, Darling Ingredients Inc., Ewald-Gelatine GmbH, GELITA AG, GELNEX, Holista Colltech Limited, LAPI GROUP SpA, Tessenderlo Group, Trobas Gelatine B.V. among others. The major players are adopting new product development and expansion strategies for global growth in the collagen & gelatin market.
Key Companies to Watch
Rousselot:
Overview: Rousselot is one the global leader in collagen-based solutions* for the food, health & nutrition, (bio)medical, and pharmaceutical sectors. The company offers Peptan, Peptan IIm, ProTake, Rousselot world-class gelatins, SiMoGel, StabiCaps, Synergy Systems, and X-Pure. It primarily serves nutrition and health, biomedical, food, pharmaceuticals, and technical market companies. Rousselot was founded in France in 1891 by Edouard Rousselot.
Product Portfolio:
X-Pure gelatins offer premium-grade solutions, with tunable functionalities and low endotoxins ≤ 10 EU/g, and are one of the most favorable biomaterials for tissue or stem cell bioengineering. X-Pure products are customizable and include X-Pure Gelatin, X-Pure GelMA, and X-Pure GelDAT.
Report Benefits
This report supports strategic decision-making by providing:
- Market size estimates and long-term revenue outlook through 2035
- Competitive benchmarking of major collagen and gelatin manufacturers
- Analysis of demand across healthcare, cosmetics, food, and biomedical applications
- Regional growth assessment and investment opportunities
- Supply chain, pricing, regulatory, and competitive landscape analysis
- Insights into product innovation, expansion strategies, mergers and acquisitions, and new product launches
Target Audience
- Collagen Manufacturers
- Gelatin Producers
- Pharmaceutical Companies
- Biotechnology Companies
- Food & Beverage Manufacturers
- Nutraceutical Companies
- Cosmetic and Personal Care Brands
- Biomedical Research Organizations
- Healthcare Providers
- Medical Device Companies
- Raw Material Suppliers
- Contract Manufacturers
- Investors and Private Equity Firms
- Procurement Teams
- Corporate Strategy Executives
- Regulatory Affairs Professionals
Conclusion
The collagen and gelatin market continues to benefit from expanding applications that extend well beyond traditional food processing into regenerative medicine, clinical nutrition, pharmaceuticals, and advanced biomaterials. Rising healthcare demand associated with aging populations and chronic disease management provides a durable foundation for sustained industry growth.
Future competitive advantage will depend on product quality, regulatory compliance, raw material traceability, biomedical innovation, and the ability to address specialized customer requirements across healthcare and nutrition markets. Companies investing in premium collagen technologies, research partnerships, and application-specific solutions are expected to be well positioned as demand continues to expand through 2035.
